Description
Intestinal Antigenic Permeability Screen Requires a blood draw.
Elevated antibodies to LPS, Occludin/Zonulin and the Actomyosin Network are patent pending biomarkers that identify the breakdown of a healthy in
testinal barrier, which allow penetration of largeantigenic molecules:
1.Lipopolysaccharides (LPS) are large molecules found in gram-negative bacteria. They are endotoxins, and if absorbed, elicit a strong immune response.The detection of antibodies against LPS reveals macromolecule-sized endotoxin infiltration through the intestinal barrier into the systemic circulation.
2.Occludin is part of the main component of proteins holding together the tight junctions. The detection of antibodies to occludin indicates that the tight junctions are breaking down. This is a measure of a mechanism involved in dama ging the intestinal barrier membrane.
3.Zonulin, a protein, regulates the permeability of the intestine. The detection of antibodies against zonulin indicates that the normal regulation of tight junctions is compromised. This can be a clue to presence of an ongoing mechanism involved in damaging the intestinal barrier.
4.The Actomyosin Network, a protein complex, regulates intestinal barrier function by maintaining the plasticity of tight junctions.
Antibodies to the actomyosin network are a biomarker of intestinal barrier dysregulation via cell infiltration. For example, 98.2% of Celiac disease patients
with flat mucosa have antibodies to actin.This is a measure of mechanism involved in damaging the intestinal barrier.
Actomyosin IgA |
( CPT CODE : 86256 ) |
Occludin/Zonulin IgG |
( CPT CODE : 86256-59 ) |
Occludin/Zonulin IgA |
( CPT CODE : 86256-59 ) |
Occludin/Zonulin IgM |
( CPT CODE : 86256-59 ) |
Lipopolysaccharides (LPS) IgG |
( CPT CODE : 86256-59 ) |
Lipopolysaccharides (LPS) IgA |
( CPT CODE : 86256-59 ) |
Lipopolysaccharides (LPS) IgM |
( CPT CODE : 86256-59 ) |